BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36437190)

  • 1. Allogeneic cord blood regulatory T cells can resolve lung inflammation.
    Lyu MA; Huang M; Zeng K; Li L; Khoury JD; Nishimoto M; Ma H; Sadeghi T; Mukherjee S; Slutsky AS; Flowers CR; Parmar S
    Cytotherapy; 2023 Mar; 25(3):245-253. PubMed ID: 36437190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
    Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
    Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells.
    Zeng K; Huang M; Lyu MA; Khoury JD; Ahmed S; Patel KK; Dropulić B; Reese-Koc J; Caimi PF; Sadeghi T; Lima M; Flowers CR; Parmar S
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation.
    Robinson KL; Ayello J; Hughes R; van de Ven C; Issitt L; Kurtzberg J; Cairo MS
    Exp Hematol; 2002 Mar; 30(3):245-51. PubMed ID: 11882362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive Characteristics of Umbilical Cord Blood-derived Regulatory T Cells After Ex Vivo Expansion on Autologous and Allogeneic T Effectors and Various Lymphoblastic Cells.
    Vanichapol T; Pongsakul N; Srisala S; Apiwattanakul N; Chutipongtanate S; Hongeng S
    J Immunother; 2019 May; 42(4):110-118. PubMed ID: 30921263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
    Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.
    Parmar S; Liu X; Tung SS; Robinson SN; Rodriguez G; Cooper LJ; Yang H; Shah N; Yang H; Konopleva M; Molldrem JJ; Garcia-Manero G; Najjar A; Yvon E; McNiece I; Rezvani K; Savoldo B; Bollard CM; Shpall EJ
    Cytotherapy; 2014 Jan; 16(1):90-100. PubMed ID: 24480547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25 (+) T cells.
    Lin SJ; Lu CH; Yan DC; Lee PT; Hsiao HS; Kuo ML
    Immunol Res; 2014 Oct; 60(1):105-11. PubMed ID: 24515612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD49d Treg cells with high suppressive capacity are remarkably less efficient on activated CD45RA- than on naive CD45RA+ Teff cells.
    Kraczyk B; Remus R; Hardt C
    Cell Physiol Biochem; 2014; 34(2):346-55. PubMed ID: 25060807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance between Subpopulations of Regulatory T Cells in Patients with Acute Exacerbation of COPD.
    Yang X; Huo B; Zhong X; Su W; Liu W; Li Y; He Z; Bai J
    COPD; 2017 Dec; 14(6):618-625. PubMed ID: 29166179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of intracellular galectin-1-expressing lymphocytes in umbilical cord blood in comparison with adult peripheral blood.
    Kollár S; Sándor N; Molvarec A; Stenczer B; Rigó J; Tulassay T; Vásárhelyi B; Toldi G
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1608-13. PubMed ID: 22609846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
    Ikewaki N; Yamao H; Kulski JK; Inoko H
    J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiply restimulated human cord blood-derived Tregs maintain stabilized phenotype and suppressive function and predict their therapeutic effects on autoimmune diabetes.
    Bi Y; Kong R; Peng Y; Cai D; Zhang Y; Yang F; Li X; Deng W; Liu F; He B; Cao C; Deng C; Tang X; Fan L; Yu H; Zhou Z
    Diabetol Metab Syndr; 2024 Mar; 16(1):71. PubMed ID: 38515175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of allogeneic cytotoxic T cell (CD8
    Kang N; Toyofuku WM; Yang X; Scott MD
    Acta Biomater; 2017 Jul; 57():146-155. PubMed ID: 28442414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
    Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
    Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenalidomide potentiates CD4
    Grygorowicz MA; Borycka IS; Nowak E; Paszkiewicz-Kozik E; Rymkiewicz G; Błachnio K; Biernacka M; Bujko M; Walewski J; Markowicz S
    Clin Exp Med; 2017 May; 17(2):193-207. PubMed ID: 26961690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.
    Lee CC; Lin SJ; Cheng PJ; Kuo ML
    Pediatr Allergy Immunol; 2009 Nov; 20(7):624-32. PubMed ID: 19302176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic-ischemic brain injury.
    McDonald CA; Penny TR; Paton MCB; Sutherland AE; Nekkanti L; Yawno T; Castillo-Melendez M; Fahey MC; Jones NM; Jenkin G; Miller SL
    J Neuroinflammation; 2018 Feb; 15(1):47. PubMed ID: 29454374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.